P1173: EARLY ADMINISTRATION OF POLATUZUMAB VEDOTIN AS BRIDGING CD19‐SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IS AN EFFECTIVE STRATEGY TO IMPROVE SURVIVAL IN PATIENTS WITH R/R B‐CELL LYMPHOMA

• Published in: HemaSphere Vol. 7; no. S3; pp. e68510b0 - n/a
• Main Authors: Yang, Fan, Liu, Rui, Fu, Zhonghua, Xu, Teng, Zheng, Peihao, Feng, Shaomei, Guo, Yuelu, MA, Lixia, Shi, Hui, Deng, Biping, Ke, Xiaoyan, Hu, Kai
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA Lippincott Williams & Wilkins 08.08.2023; Wiley